131 filings
Page 4 of 7
6-K
IMTX
Immatics N.V
14 Dec 21
Current report (foreign)
7:22am
6-K
IMTX
Immatics N.V
16 Nov 21
Current report (foreign)
7:42am
6-K
IMTX
Immatics N.V
9 Nov 21
Current report (foreign)
8:08am
6-K
IMTX
Immatics N.V
1 Nov 21
Immatics to Present Update on Lead ACTengine® Program IMA203 Targeting PRAME at the Society for Immunotherapy of Cancer’s 36th Annual Meeting
8:25am
6-K/A
IMTX
Immatics N.V
28 Oct 21
Current report (foreign) (amended)
8:14am
6-K/A
IMTX
Immatics N.V
28 Oct 21
Current report (foreign) (amended)
8:10am
20-F/A
2020 FY
IMTX
Immatics N.V
28 Oct 21
Annual report (foreign) (amended)
8:04am
6-K
IMTX
Immatics N.V
10 Aug 21
Current report (foreign)
8:19am
EFFECT
IMTX
Immatics N.V
10 Aug 21
Notice of effectiveness
12:15am
EFFECT
IMTX
Immatics N.V
6 Aug 21
Notice of effectiveness
12:15am
UPLOAD
IMTX
Immatics N.V
6 Aug 21
Letter from SEC
12:00am
CORRESP
IMTX
Immatics N.V
6 Aug 21
Correspondence with SEC
12:00am
POS AM
IMTX
Immatics N.V
2 Aug 21
Prospectus update (post-effective amendment)
9:26am
F-3
IMTX
Immatics N.V
2 Aug 21
Shelf registration (foreign)
9:22am
UPLOAD
IMTX
Immatics N.V
30 Jul 21
Letter from SEC
12:00am
CORRESP
IMTX
Immatics N.V
21 Jul 21
Correspondence with SEC
12:00am
6-K
IMTX
Immatics N.V
15 Jul 21
Current report (foreign)
7:05am
UPLOAD
IMTX
Immatics N.V
1 Jul 21
Letter from SEC
12:00am
424B3
IMTX
Immatics N.V
22 Jun 21
Prospectus supplement
4:32pm
6-K
IMTX
Immatics N.V
22 Jun 21
Annual General Meeting of Shareholders
4:30pm